Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia
Autor(a) principal: | |
---|---|
Data de Publicação: | 2005 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
dARK ID: | ark:/48912/0013000012kzd |
Texto Completo: | http://dx.doi.org/10.1590/S0004-28032005000100008 http://repositorio.unifesp.br/handle/11600/2442 |
Resumo: | BACKGROUND: Higher proliferation is commonly observed in cancer cells. Apoptosis can be a useful measure of a tumor cell kinetic. Alteration of the balance between proliferation and apoptosis is associated with cancer. AIM: To study proliferation and apoptosis on gastric cancer and in intestinal metaplasia. METHODOLOGY: Twenty-two samples from gastric adenocarcinomas and 22 biopsies from intestinal metaplasia were studied. The apoptotic bodies in hematoxylin-eosin slides and the expression of p53, bcl-2 and Ki67 were determined by immunohistochemistry. RESULTS: The number of the apoptotic cells was higher in cancer. Ki 67LI increased from intestinal metaplasia to gastric cancer. p53 was positive in 68% of the patients with cancer, more frequently in advanced stage and negative in samples of intestinal metaplasia. Although there was no significant difference between the groups, bcl-2 was positive in 45% of gastric cancer tissue and in 68% of metaplasia. In gastric cancer patients bcl-2 was expressed in early gastric cancer more frequently than in advanced stage. CONCLUSION: The positivity of bcl-2 was higher in metaplasia and probably is involved in the progression of carcinogenesis. p53 was negative in metaplasia and positive in more than half of the gastric cancer, mostly in stage IV, suggesting a late event in gastric cancer. |
id |
UFSP_56b3c9f52bcaba8473186529fd5b6d80 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/2442 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Cell proliferation and apoptosis in gastric cancer and intestinal metaplasiaProliferação celular e apoptose em câncer gástrico e metaplasia intestinalApoptosisProtein p53Proto-oncogene proteinsProto-oncogene proteins c-Bcl-2Stomach neoplasmsMetaplasiaApoptoseProteína p53Proteínas proto-oncogênicasProteínas proto-oncogênicas c-Bcl-2Neoplasias gástricasMetaplasiaBACKGROUND: Higher proliferation is commonly observed in cancer cells. Apoptosis can be a useful measure of a tumor cell kinetic. Alteration of the balance between proliferation and apoptosis is associated with cancer. AIM: To study proliferation and apoptosis on gastric cancer and in intestinal metaplasia. METHODOLOGY: Twenty-two samples from gastric adenocarcinomas and 22 biopsies from intestinal metaplasia were studied. The apoptotic bodies in hematoxylin-eosin slides and the expression of p53, bcl-2 and Ki67 were determined by immunohistochemistry. RESULTS: The number of the apoptotic cells was higher in cancer. Ki 67LI increased from intestinal metaplasia to gastric cancer. p53 was positive in 68% of the patients with cancer, more frequently in advanced stage and negative in samples of intestinal metaplasia. Although there was no significant difference between the groups, bcl-2 was positive in 45% of gastric cancer tissue and in 68% of metaplasia. In gastric cancer patients bcl-2 was expressed in early gastric cancer more frequently than in advanced stage. CONCLUSION: The positivity of bcl-2 was higher in metaplasia and probably is involved in the progression of carcinogenesis. p53 was negative in metaplasia and positive in more than half of the gastric cancer, mostly in stage IV, suggesting a late event in gastric cancer.RACIONAL: O aumento da proliferação celular é comumente observado no câncer e a apoptose pode ser medida útil na avaliação da cinética celular do tumor. Alterações do equilíbrio entre proliferação celular e apoptose estão associadas ao câncer. OBJETIVO: Avaliar a proliferação celular e a apoptose no câncer gástrico e na metaplasia intestinal. CASUÍSTICA E MÉTODOS: Vinte e dois tecidos de adenocarcinoma gástrico e 22 biopsias de metaplasia intestinal foram estudados. Os corpos apoptóticos foram estudados em lâminas coradas pela hematoxilina-eosina e a expressão de p53, bcl-2 e Ki67 por imunoistoquímica. RESULTADOS: O número de corpos apoptóticos foi maior no câncer. O Ki67LI aumentou no câncer gástrico em relação ao tecido com metaplasia intestinal. O p53 foi positivo em 68% dos pacientes com câncer, principalmente nos tumores avançados e negativo nos indivíduos com metaplasia intestinal. O bcl-2 foi expresso em 45% dos tecidos com câncer gástrico e em 68% dos tecidos com metaplasia, no entanto, esta diferença não foi significante. Nos doentes com câncer gástrico precoce, o bcl-2 foi expresso com maior freqüência quando comparados aos com câncer em estádio avançado. CONCLUSÃO: A expressão do bcl-2 foi maior no tecido com metaplasia, sugerindo envolvimento desta proteína na evolução da carcinogênese. O p53 foi negativo nos tecidos com metaplasia intestinal e positivo em 50% dos tecidos tumorais, principalmente nos doentes com câncer estádio IV, sugerindo ser um evento tardio no câncer gástrico.IOncology Group Gastroenterology DivisionPathology DepartmentFederal University of São Paulo Surgical Gastroenterology DivisionUNIFESP, Surgical Gastroenterology DivisionSciELOInstituto Brasileiro de Estudos e Pesquisas de Gastroenterologia - IBEPEGE Colégio Brasileiro de Cirurgia Digestiva - CBCD Sociedade Brasileira de Motilidade Digestiva - SBMD Federação Brasileira de Gastroenterologia - FBGSociedade Brasileira de Hepatologia - SBHSociedade Brasileira de Endoscopia Digestiva - SOBEDIOncology Group Gastroenterology DivisionPathology DepartmentUniversidade Federal de São Paulo (UNIFESP)Forones, Nora Manoukian [UNIFESP]Carvalho, Ana Paula SouzaGiannotti-Filho, OswaldoLourenço, Laércio Gomes [UNIFESP]Oshima, Celina Tizuko Fujiyama [UNIFESP]2015-06-14T13:31:29Z2015-06-14T13:31:29Z2005-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion30-34application/pdfhttp://dx.doi.org/10.1590/S0004-28032005000100008Arquivos de Gastroenterologia. Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia - IBEPEGE Colégio Brasileiro de Cirurgia Digestiva - CBCD Sociedade Brasileira de Motilidade Digestiva - SBMD Federação Brasileira de Gastroenterologia - FBGSociedade Brasileira de Hepatologia - SBHSociedade Brasileira de Endoscopia Digestiva - SOBED, v. 42, n. 1, p. 30-34, 2005.10.1590/S0004-28032005000100008S0004-28032005000100008.pdf0004-2803S0004-28032005000100008http://repositorio.unifesp.br/handle/11600/2442ark:/48912/0013000012kzdengArquivos de Gastroenterologiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-05T17:16:00Zoai:repositorio.unifesp.br/:11600/2442Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-12-11T20:51:41.576853Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia Proliferação celular e apoptose em câncer gástrico e metaplasia intestinal |
title |
Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia |
spellingShingle |
Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia Forones, Nora Manoukian [UNIFESP] Apoptosis Protein p53 Proto-oncogene proteins Proto-oncogene proteins c-Bcl-2 Stomach neoplasms Metaplasia Apoptose Proteína p53 Proteínas proto-oncogênicas Proteínas proto-oncogênicas c-Bcl-2 Neoplasias gástricas Metaplasia |
title_short |
Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia |
title_full |
Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia |
title_fullStr |
Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia |
title_full_unstemmed |
Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia |
title_sort |
Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia |
author |
Forones, Nora Manoukian [UNIFESP] |
author_facet |
Forones, Nora Manoukian [UNIFESP] Carvalho, Ana Paula Souza Giannotti-Filho, Oswaldo Lourenço, Laércio Gomes [UNIFESP] Oshima, Celina Tizuko Fujiyama [UNIFESP] |
author_role |
author |
author2 |
Carvalho, Ana Paula Souza Giannotti-Filho, Oswaldo Lourenço, Laércio Gomes [UNIFESP] Oshima, Celina Tizuko Fujiyama [UNIFESP] |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
IOncology Group Gastroenterology Division Pathology Department Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Forones, Nora Manoukian [UNIFESP] Carvalho, Ana Paula Souza Giannotti-Filho, Oswaldo Lourenço, Laércio Gomes [UNIFESP] Oshima, Celina Tizuko Fujiyama [UNIFESP] |
dc.subject.por.fl_str_mv |
Apoptosis Protein p53 Proto-oncogene proteins Proto-oncogene proteins c-Bcl-2 Stomach neoplasms Metaplasia Apoptose Proteína p53 Proteínas proto-oncogênicas Proteínas proto-oncogênicas c-Bcl-2 Neoplasias gástricas Metaplasia |
topic |
Apoptosis Protein p53 Proto-oncogene proteins Proto-oncogene proteins c-Bcl-2 Stomach neoplasms Metaplasia Apoptose Proteína p53 Proteínas proto-oncogênicas Proteínas proto-oncogênicas c-Bcl-2 Neoplasias gástricas Metaplasia |
description |
BACKGROUND: Higher proliferation is commonly observed in cancer cells. Apoptosis can be a useful measure of a tumor cell kinetic. Alteration of the balance between proliferation and apoptosis is associated with cancer. AIM: To study proliferation and apoptosis on gastric cancer and in intestinal metaplasia. METHODOLOGY: Twenty-two samples from gastric adenocarcinomas and 22 biopsies from intestinal metaplasia were studied. The apoptotic bodies in hematoxylin-eosin slides and the expression of p53, bcl-2 and Ki67 were determined by immunohistochemistry. RESULTS: The number of the apoptotic cells was higher in cancer. Ki 67LI increased from intestinal metaplasia to gastric cancer. p53 was positive in 68% of the patients with cancer, more frequently in advanced stage and negative in samples of intestinal metaplasia. Although there was no significant difference between the groups, bcl-2 was positive in 45% of gastric cancer tissue and in 68% of metaplasia. In gastric cancer patients bcl-2 was expressed in early gastric cancer more frequently than in advanced stage. CONCLUSION: The positivity of bcl-2 was higher in metaplasia and probably is involved in the progression of carcinogenesis. p53 was negative in metaplasia and positive in more than half of the gastric cancer, mostly in stage IV, suggesting a late event in gastric cancer. |
publishDate |
2005 |
dc.date.none.fl_str_mv |
2005-03-01 2015-06-14T13:31:29Z 2015-06-14T13:31:29Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S0004-28032005000100008 Arquivos de Gastroenterologia. Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia - IBEPEGE Colégio Brasileiro de Cirurgia Digestiva - CBCD Sociedade Brasileira de Motilidade Digestiva - SBMD Federação Brasileira de Gastroenterologia - FBGSociedade Brasileira de Hepatologia - SBHSociedade Brasileira de Endoscopia Digestiva - SOBED, v. 42, n. 1, p. 30-34, 2005. 10.1590/S0004-28032005000100008 S0004-28032005000100008.pdf 0004-2803 S0004-28032005000100008 http://repositorio.unifesp.br/handle/11600/2442 |
dc.identifier.dark.fl_str_mv |
ark:/48912/0013000012kzd |
url |
http://dx.doi.org/10.1590/S0004-28032005000100008 http://repositorio.unifesp.br/handle/11600/2442 |
identifier_str_mv |
Arquivos de Gastroenterologia. Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia - IBEPEGE Colégio Brasileiro de Cirurgia Digestiva - CBCD Sociedade Brasileira de Motilidade Digestiva - SBMD Federação Brasileira de Gastroenterologia - FBGSociedade Brasileira de Hepatologia - SBHSociedade Brasileira de Endoscopia Digestiva - SOBED, v. 42, n. 1, p. 30-34, 2005. 10.1590/S0004-28032005000100008 S0004-28032005000100008.pdf 0004-2803 S0004-28032005000100008 ark:/48912/0013000012kzd |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Arquivos de Gastroenterologia |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
30-34 application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia - IBEPEGE Colégio Brasileiro de Cirurgia Digestiva - CBCD Sociedade Brasileira de Motilidade Digestiva - SBMD Federação Brasileira de Gastroenterologia - FBGSociedade Brasileira de Hepatologia - SBHSociedade Brasileira de Endoscopia Digestiva - SOBED |
publisher.none.fl_str_mv |
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia - IBEPEGE Colégio Brasileiro de Cirurgia Digestiva - CBCD Sociedade Brasileira de Motilidade Digestiva - SBMD Federação Brasileira de Gastroenterologia - FBGSociedade Brasileira de Hepatologia - SBHSociedade Brasileira de Endoscopia Digestiva - SOBED |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1818602557299228672 |